首页
订购/客服:400-666-5481

Garenoxacin

    
≥98%

Garenoxacin

源叶(MedMol)
S84509 一键复制产品信息
223652-90-2
C23H20F2N2O4.CH4O3S.H2O
540.53
1-环丙基-8-(二氟甲氧基)-7-[(1R)-2,3-二氢-1-甲基-1H-异吲哚-5-基]-1,4-二氢-4-氧代-3-喹啉甲酸甲磺酸盐一水合物;甲磺酸加雷沙星一水合物;甲磺酸加雷沙星;1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-3-quin
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S84509-5mg
≥98%

¥410.00

货期:3-5天 - - - -
S84509-10mg
≥98%

¥660.00

货期:3-5天 - - - -
S84509-50mg
≥98%

¥1980.00

货期:3-5天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: Garenoxacin (BMS284756) Mesylate hydrate is an orally active quinolone antibiotic and has a broad spectrum of activity against a wide array of gram-positive and gram-negative bacteria, anaerobes, and fastidious organisms
靶点: Quinolone;Gyrase:1.25 μg/mL (IC50);TOPO IV:1.5-2.5 μg/mL (IC50);Antibacterial
体内研究: Garenoxacin (12.5-50 mg/kg; s.c.; once) is highly effective against the wild-type strain and mutants harboring a single mutation in a mouse pneumonia model with S. pneumonia infection. Garenoxacin (10 and 30 mg/kg; p.o.; once) reduces the viable cell counts in the lungs and significantly prolongs survival on experimental secondary pneumococcal pneumonia caused by S. pneumoniae D-979 in BALB/c female mice Animal Model: Swiss mice with S. pneumonia infection. Dosage: 12.5, 25 and 50 mg/kg Administration: Subcutaneous injection, once Result: Significantly improved the survival rate.
参考文献: 1. Waites KB, et al. In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob Agents Chemother. 2003 Jan;47(1):161-5. 2. Ince D, et al. Dual targeting of DNA gyrase and topoisomerase IV: target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone. Antimicrob Agents Chemother. 2002 Nov;46(11):3370-80. 3. Zhao X, et al. Mutant prevention concentration of garenoxacin (BMS-284756) for ciprofloxacin-susceptible or -resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2003 Mar;47(3):1023-7. [Content Brief] 4. Azoulay-Dupuis E, et al. Activities of garenoxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model. Antimicrob Agents Chemother. 2004 Mar;48(3):765-73. 5. Fukuda Y, et al. Therapeutic effects of garenoxacin in murine experimental secondary pneumonia by Streptococcus pneumoniae after influenza virus infection. Diagn Microbiol Infect Dis. 2014 Feb;78(2):168-71.
溶解性: Soluble  in  DMSO、H2O
保存条件: 2-8℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 1.85 ml 9.25 ml 18.5 ml
5 mM 0.37 ml 1.85 ml 3.7 ml
10 mM 0.185 ml 0.925 ml 1.85 ml
50 mM 0.037 ml 0.185 ml 0.37 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×